ARCHIVES

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

In Congress: DOD Cancer Research Programs Increased; Senate Passes NIH Funding Bill; Porter Won’t Seek Re-election

October 22, 1999

Environmental Carcinogenesis Gets 17% Of NCI Budget

February 20, 1976

Trials Approved by NCI CTEP For the Month of May

May 25, 2012

The Cancer Letter Wins Journalism Award

April 1, 2011

NCAB Grants Three MERIT Awards; Rimer To Leave NCI For Post At UNC

June 21, 2002

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

September 3, 1976